Regeneron Pharmaceuticals, Inc. REGN
920.69 USD -1.71 (-0.19%)
Regular-session close
920.69 0.00 0.00%
After hours · Nov 20, 6:14 PM ET
916.66 Day range 948.42
600.66 52-week range 973.36
- YTD
- +19.28%
- 1 year
- +24.92%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.34B | 14.20B | 13.12B | 12.17B | 16.07B | |
| 12.24B | 12.23B | 11.30B | 10.61B | 13.63B | |
| 3.58B | 3.99B | 4.05B | 4.74B | 8.95B | |
| 4.50B | 4.41B | 3.95B | 4.34B | 8.08B | |
| 41.48 | 38.34 | 34.77 | 38.22 | 71.97 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.12B | 2.49B | 2.73B | 3.11B | 2.89B | |
| 40.56B | 37.76B | 33.08B | 29.21B | 25.43B | |
| 9.30B | 8.41B | 7.11B | 6.55B | 6.67B | |
| 2.71B | 2.70B | 2.70B | 2.70B | 2.70B | |
| 31.26B | 29.35B | 25.97B | 22.66B | 18.77B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 4.98B | 4.42B | 4.59B | 5.01B | 7.08B | |
| -629.10M | -2.47B | -3.19B | -3.78B | -5.38B | |
| -3.72B | -2.20B | -1.79B | -1.01B | -1.01B | |
| -898.40M | -735.80M | -718.60M | -590.10M | -551.90M | |
| 634.70M | -248.80M | -381.60M | 221.30M | 690.80M |
